Use of selegiline to treat hearing loss in mammals

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/137 (2006.01) A61P 27/16 (2006.01)

Patent

CA 2221255

Selegiline and pharmaceutically acceptable analog forms thereof are used as treatments for hearing loss in mammals, especially dogs.

On utilise la sélégiline ainsi que des formes analogues de celle-ci, acceptables du point de vue pharmaceutique, comme moyens thérapeutiques de la perte d'audition chez des mammifères, des chiens notamment.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of selegiline to treat hearing loss in mammals does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of selegiline to treat hearing loss in mammals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of selegiline to treat hearing loss in mammals will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1369582

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.